Riverwater Partners’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.37M | Sell |
13,182
-31
| -0.2% | -$5.57K | 1.12% | 21 |
|
2025
Q1 | $2.24M | Buy |
13,213
+2,855
| +28% | +$483K | 1.15% | 20 |
|
2024
Q4 | $1.56M | Buy |
10,358
+152
| +1% | +$22.9K | 0.76% | 37 |
|
2024
Q3 | $1.58M | Buy |
10,206
+27
| +0.3% | +$4.18K | 0.78% | 36 |
|
2024
Q2 | $1.39M | Sell |
10,179
-56
| -0.5% | -$7.67K | 1.03% | 20 |
|
2024
Q1 | $1.36M | Buy |
10,235
+3,559
| +53% | +$474K | 1% | 21 |
|
2023
Q4 | $921K | Buy |
6,676
+45
| +0.7% | +$6.21K | 0.73% | 33 |
|
2023
Q3 | $808K | Buy |
6,631
+2,114
| +47% | +$258K | 0.73% | 34 |
|
2023
Q2 | $635K | Buy |
4,517
+204
| +5% | +$28.7K | 0.56% | 53 |
|
2023
Q1 | $610K | Buy |
4,313
+63
| +1% | +$8.91K | 0.56% | 53 |
|
2022
Q4 | $665K | Buy |
4,250
+194
| +5% | +$30.4K | 0.57% | 54 |
|
2022
Q3 | $498K | Hold |
4,056
| – | – | 0.5% | 63 |
|
2022
Q2 | $539K | Buy |
4,056
+284
| +8% | +$37.7K | 0.54% | 55 |
|
2022
Q1 | $516K | Sell |
3,772
-1,948
| -34% | -$266K | 0.85% | 53 |
|
2021
Q4 | $990K | Buy |
+5,720
| New | +$990K | 0.88% | 27 |
|